Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds

Stock Information for Covalon Technologies Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Covalon Technologies Ltd.

Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024
Covalon Announces First Quarter Fiscal 2024 Results
Covalon Announces Management Changes
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
Covalon's VALGuard Gains Prestigious Recognition in the British Journal of Nursing
Covalon Announces Issuance of Deferred Share Units

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.